USADA has handed down a one-year suspension to PFL light heavyweight and former Bellator MMA title challenger Karl More.
The fine print isn’t pretty.
Moore, who faced Corey Anderson last year for the Bellator light heavyweight championship, has been suspended 12 months, six more than normal, for his first infraction under the PFL’s Anti-Doping Policy, which is administered by USADA (the U.S. Anti-Doping Agency, who previously spearheaded the UFC’s anti-doping program).
Per a press release issued on Thursday, Moore (12-4) “tested positive for recombinant erythropoietin (rEPO) as the result of an out-of-competition sample collected on April 9, 2025.”
That in and of itself is bad. The next part gets worse.
“Under Section 10.2 of the current version of the PFL ADP, the default period of ineligibility for the use of a prohibited substance is six months but can be increased up to a year in certain circumstances. Here, Moore received a one-year period of ineligibility because his reckless conduct—injecting an unlabeled drug that did not belong to him—led to his positive test. Moore’s one-year period of ineligibility began on April 9, 2025, the date his positive sample was collected.”
Moore’s suspension is backdated to April 9, 2025, the date on which his drug test sample was collected. He was last seen losing a split decision against Antonio Carlos Junior on May 1, as part of the PFL World Tournament. Coincidentally, ACJ won the tournament at PFL Hollywood on the same day Moore’s sanction was announced.
